Changes in folate supplementation, and in serum and red cell folate levels in antenatal patients over the course of a health promotion project for the prevention of neural tube defects

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 37, Issue 3, 1997, Pages 267-271

  Bower, Carol ^a   Knowles, Simon ^a   Nicol, Darryl ^b  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; FOLIC ACID BLOOD LEVEL; HEALTH PROMOTION; HUMAN; HUMAN EXPERIMENT; NEURAL TUBE DEFECT; NORMAL HUMAN; PRENATAL CARE; PRENATAL PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0030739816     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828x.1997.tb02406.x     Document Type: Article

References (16)

1. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study Research Group. Lancet 1991; 338: 131-137.
2. Czeizel A, Dudas I. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. New Engl J Med 1992; 327: 1832-1835.
3. Bower C, Stanley F. Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989; 150: 613-619.
4. Milunsky A, Jick H, Jick S, Bruell C et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847-2852.
5. Werler M, Shapiro A, Mitchell A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269: 1257-1261.
6. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate and the occurrence of neural tube defects. Epidemol 1995; 6: 219-226.
7. Friel JK, Frecker M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet 1995; 55: 195-199.
8. Bower C, Blum L, Watson C, Stanley F. Folate and the prevention of neural tube defects: evaluation of a health promotion project in Western Australia. Health Promotion International 1996; 11: 177-187.
9. Bower C, Blum L, Ng ML, Irvin C, Kurinczuk J. Folate and the prevention of neural tube defects: the pharmacist's contribution. Australian Pharmacist 1995; 14: 367-371.
10. Davis RE, Nicol DJ, Kelly A. An automated method for the measurement of folate activity. J Clin Pathol 1970; 23: 47-53.
11. Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. Prepregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake. Med J Aust 1995; 162: 403-406.
12. Higgins CJ, Kosky CA, Loutsky FK, O'Daly KJ. Knowledge and intake of periconceptional folate in pregnant women subsequent to the Western Australian Folate and Neural Tube Defects Prevention Project (1992-1994). Unpublished report 9519, Department of Public Health, University of Western Australia, 1995.
13. De Jong-Van den berg LTW, Cornel MC, Tymstra T, Buitendijk SE. Folate prophylaxis in pregnancy. Lancet 1995; 346: 1227-1228.
14. Sutcliffe M, Wild J, Perry A, Schorah CJ. Prevention of neural tube defects. Lancet 1994; 344: 1578.
15. National Health and Medical Research Council; Commonwealth of Australia. Revised statement on the relationship between dietary folic acid and neural tube defects such as spina bifida. Approved at the 113rd session, June, 1993.
16. Folate Fortification. Report of the Expert Panel on folate fortification. National Health and Medical Research Council, Australian Government Printing Office, 1995.